NC
ABBV icon

North Capital’s AbbVie ABBV Stock Holding History

North Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$483K Sell
1,920
-28
-1% -$6.02K 0.37% 41
2026
Q1 		$424K Hold
1,948
– – 0.36% 41
2025
Q4 		$445K Buy
1,948
+99
+5% +$22.6K 0.38% 39
2025
Q3 		$428K Buy
1,849
+188
+11% +$38.3K 0.33% 38
2025
Q2 		$308K Sell
1,661
-178
-10% -$33.1K 0.27% 52
2025
Q1 		$385K Buy
+1,839
New +$358K 0.36% 37

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

North Capital's ABBV Position: Q2 2026 in Review

North Capital reduced its AbbVie (ABBV) stake by 1.4% in Q2 2026, selling an estimated $6.02K and leaving 1,920 shares worth $483K. The position accounts for 0.37% of the portfolio, ranked #41.

North Capital first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • North Capital held 1,920 shares of AbbVie worth $483K as of Q2 2026.
  • North Capital sold 28 AbbVie shares in Q2 2026, an estimated $6.02K.
  • AbbVie made up 0.37% of North Capital's portfolio in Q2 2026, its #41 holding.
  • North Capital first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on North Capital's 13F filing for Q2 2026, filed 14 Jul 2026.